8-K: ADM Reports Third Quarter Results, Files Restated 2023 Financials

Archer-Daniels-Midland Company (ADM) announced its third quarter 2024 financial results, consistent with preliminary figures, and filed restated financial statements for fiscal year 2023 and the first two quarters of 2024.

Summary

• ADM reported third quarter 2024 net earnings of $18 million, or $0.04 per share, and adjusted net earnings of $530 million, or $1.09 per share.
• The company recorded a $461 million non-cash impairment charge related to its Wilmar equity investment.
• Trailing four-quarter average return on invested capital (ROIC) was 6.6%, and adjusted ROIC was 8.8%.
• Year-to-date cash flows from operating activities were $2,468 million, with cash flows from operations before working capital of $2,341 million.
• The restatement of prior financial statements had no impact on the company's consolidated financial results for 2023 and the first two quarters of 2024.
• Total segment operating profit for the third quarter was $1,037 million, down 28% compared to the prior year quarter.
• Year-to-date total segment operating profit was $3,158 million, a decrease of 32% compared to the prior year period.
• The company affirmed its full-year 2024 adjusted earnings per share guidance of $4.50 to $5.00.

Sentiment

Score: 4

Explanation: The document presents mixed results with significant declines in earnings and a large impairment charge, offset by some positive segment performance and reaffirmed guidance. The overall tone is cautious, reflecting the challenges the company faces.

Positives

• The restatement of prior financial statements had no impact on the company's consolidated financial results.
• The Starches & Sweeteners subsegment saw a 13% increase in operating profit due to strong volumes and margins.
• Animal Nutrition subsegment operating profit increased by 58% due to cost optimization and lower input costs.
• Equity earnings from the Wilmar investment were $62 million for the quarter, up from $35 million in the prior year quarter.
• The company received $24 million in insurance proceeds for the partial settlement of the Decatur East and West insurance claims related to incidents in 2023.
• The company received $47 million of insurance proceeds for the partial settlement of the Decatur West insurance claims related to an incident that occurred in 2023.
• The company received $25 million of insurance proceeds for the partial settlement of the Decatur East insurance claims related to an incident that occurred in 2023.

Negatives

• Net earnings and earnings per share were down significantly compared to the prior year period.
• The company recorded a $461 million non-cash impairment charge related to its Wilmar equity investment.
• Ag Services & Oilseeds segment operating profit decreased by 43% in the third quarter.
• The Refined Products & Other subsegment operating profit was down 63% due to lower refining and biodiesel margins.
• Human Nutrition subsegment operating profit was down 27% due to various factors including non-recurring benefits in the prior year period and costs associated with the closure of a joint venture.
• Carbohydrate Solutions segment operating profit was down 3% for the quarter and 1% year to date.
• The company anticipates lower year-over-year segment operating profit in AS&O for the fourth quarter.

Risks

• The company faces softer market conditions into next year.
• There are ongoing headwinds from slower market demand and internal operational challenges.
• The company is continuing to evaluate trends in the trading price of its Wilmar equity investment and the potential for future charges.
• The company faces legislative and regulatory policy uncertainties.
• The company anticipates lower year-over-year segment operating profit in AS&O for the fourth quarter due to lower margins in Crushing and Refined Products & Other.
• The company anticipates the fourth quarter operating profit in Nutrition will be lower than the third quarter of 2024 due to softer consumer demand, lower texturants pricing, and ongoing operational challenges, including prolonged downtime at Decatur East.

Future Outlook

The company expects adjusted earnings per share in the range of $4.50 to $5.00 for the full year 2024, while anticipating softer market conditions into next year. They foresee lower year-over-year segment operating profit in AS&O for the fourth quarter, and Nutrition operating profit to be higher than the prior year period, but lower than the third quarter of 2024.

Management Comments

• Accuracy and transparency is important to the Company and we are pleased to have now completed the restatement and be current with our financial filing, said Chair of the Board and CEO Juan Luciano.
• We continue to focus on implementing enhancements to internal controls to ensure integrity and accuracy of reporting.
• Looking ahead, while we foresee softer market conditions into next year, we are taking actions to improve performance and drive value creation.
• We are redoubling our focus on productivity and operational excellence, while maintaining our disciplined approach to capital allocation.

Industry Context

This announcement comes amid a challenging period for the agricultural sector, with fluctuating commodity prices and supply chain disruptions. The company's performance reflects these broader industry trends, particularly in the Ag Services & Oilseeds segment, which is sensitive to global supply and demand dynamics. The restatement of financials highlights the importance of regulatory compliance and accurate reporting in the industry.

Comparison to Industry Standards

• ADM's adjusted ROIC of 8.8% is a key metric to compare against peers like Bunge (BG) and Cargill, which also operate in the agricultural processing and trading space. Bunge's ROIC has been in the range of 7-10% in recent periods, suggesting ADM's performance is within the typical range for the industry, but on the lower end.
• The $461 million impairment charge related to the Wilmar investment is a significant event that will likely be scrutinized by investors. Similar charges have been seen in other companies with international investments, such as those in the energy sector, where market volatility can lead to impairments.
• ADM's year-to-date cash flow from operations of $2,468 million is a critical indicator of its financial health. Comparing this to peers like Ingredion (INGR), which has a similar market cap, shows that ADM's cash flow is relatively strong, although Ingredion's cash flow is typically more stable due to its focus on value-added ingredients.
• The company's full-year adjusted EPS guidance of $4.50 to $5.00 is a benchmark that investors will use to assess its performance against expectations. Analysts will compare this to the guidance of other agricultural companies, such as Corteva (CTVA), which has a different business model but is also affected by agricultural market conditions.

Stakeholder Impact

• Shareholders will be concerned about the significant decrease in earnings and the impairment charge.
• Employees may be affected by the company's focus on productivity and operational excellence.
• Customers may see changes in product availability or pricing due to market conditions.
• Suppliers may be impacted by changes in the company's procurement strategies.
• Creditors will be monitoring the company's financial health and cash flow.

Next Steps

• The company will host a webcast on December 3, 2024, to discuss financial results and outlook.
• The company will continue to focus on implementing enhancements to internal controls.
• The company will continue to evaluate trends in the trading price of its Wilmar equity investment.

Key Dates

Keywords

financial results, earnings, restatement, segment operating profit, impairment, Wilmar, ROIC, cash flow, agriculture, nutrition